Horizon Discovery Joins Personalized Medicine Consortium; Gets Grant

The firm joined the Personalized RNA Interference to Enhance the Delivery of Individualised Cytotoxic and Targeted therapeutics consortium, and received a €300,000 grant.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories